Lucid Diagnostics Inc. (LUCD) Tops Q1 EPS by 4c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.06 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• DBS Group Downgrades RoboSense Technology (2498:HK) to Hold
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch